| 2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | Hsieh, SM; Liu, MC; Chen, YH; Lee, WS; Hwang, SJ; Cheng, SH; Ko, WC; Hwang, KP; Wang, NC; Lee, YL; Lin, YL ; Shih, SR; Huang, CG; Liao, CC ; Liang, JJ; Chang, CS; Chen, C; Lien, CE; Tai, IC; Lin, TY | The Lancet. Respiratory medicine 9(12), 1396-1406 | | | |
| 2020 | Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient | Zhou, D; Duyvesteyn, HME; Chen, CP; Huang, CG; Chen, TH; Shih, SR; Lin, YC; Cheng, CY; Cheng, SH; Huang, YC; Lin, TY; Ma, C ; Huo, J; Carrique, L; Malinauskas, T; Ruza, RR; Shah, PNM; Tan, TK; Rijal, P; Donat, RF; Godwin, K; Buttigieg, KR; Tree, JA; Radecke, J; Paterson, NG; Supasa, P; Mongkolsapaya, J; Screaton, GR; Carroll, MW; Gilbert-Jaramillo, J; Knight, ML; James, W; Owens, RJ; Naismith, JH; Townsend, AR; Fry, EE; Zhao, Y; Ren, J; Stuart, DI; Huang, KYA | Nature Structural & Molecular Biology 27, 950-958 | | | |
